摘要
<正>The CRISPR-Cas9 system, serving as a powerful genome-editing technology, has revolutionized the life sciences. However, it exhibits off-target activities that may present severe problems in clinical applications. Although a great number of in silico models have been developed to predict CRISPR targeting efficiency and specificity, they are running into a bottleneck with the lack of a mechanistic understanding of the on-and off-target activities of Cas9.
- 单位